231 related articles for article (PubMed ID: 28195317)
1. Human papillomavirus self-sampling for screening nonattenders: Opt-in pilot implementation with electronic communication platforms.
Lam JU; Rebolj M; Møller Ejegod D; Pedersen H; Rygaard C; Lynge E; Thirstrup Thomsen L; Krüger Kjaer S; Bonde J
Int J Cancer; 2017 May; 140(10):2212-2219. PubMed ID: 28195317
[TBL] [Abstract][Full Text] [Related]
2. Comparison of two invitation-based methods for human papillomavirus (HPV) self-sampling with usual care among un- and under-screened Māori, Pacific and Asian women: study protocol for a randomised controlled community trial to examine the effect of self-sampling on participation in cervical-cancer screening.
Brewer N; Bartholomew K; Maxwell A; Grant J; McPherson G; Wihongi H; Bromhead C; Scott N; Crengle S; Cunningham C; Douwes J; Potter JD
BMC Cancer; 2019 Dec; 19(1):1198. PubMed ID: 31815615
[TBL] [Abstract][Full Text] [Related]
3. Study protocol of the CHOiCE trial: a three-armed, randomized, controlled trial of home-based HPV self-sampling for non-participants in an organized cervical cancer screening program.
Tranberg M; Bech BH; Blaakær J; Jensen JS; Svanholm H; Andersen B
BMC Cancer; 2016 Nov; 16(1):835. PubMed ID: 27809810
[TBL] [Abstract][Full Text] [Related]
4. Randomized Intervention of Self-Collected Sampling for Human Papillomavirus Testing in Under-Screened Rural Women: Uptake of Screening and Acceptability.
Racey CS; Gesink DC; Burchell AN; Trivers S; Wong T; Rebbapragada A
J Womens Health (Larchmt); 2016 May; 25(5):489-97. PubMed ID: 26598955
[TBL] [Abstract][Full Text] [Related]
5. Preventing cervical cancer using HPV self-sampling: direct mailing of test-kits increases screening participation more than timely opt-in procedures - a randomized controlled trial.
Tranberg M; Bech BH; Blaakær J; Jensen JS; Svanholm H; Andersen B
BMC Cancer; 2018 Mar; 18(1):273. PubMed ID: 29523108
[TBL] [Abstract][Full Text] [Related]
6. [Utilization of self-sampling kits for HPV testing in cervical cancer screening - pilot study].
Ondryášová H; Koudeláková V; Drábek J; Vaněk P; Slavkovský R; Hajdúch M
Ceska Gynekol; 2015 Dec; 80(6):436-43. PubMed ID: 26741158
[TBL] [Abstract][Full Text] [Related]
7. Uptake of community-based, self-collected HPV testing vs. visual inspection with acetic acid for cervical cancer screening in Kampala, Uganda: preliminary results of a randomised controlled trial.
Moses E; Pedersen HN; Mitchell SM; Sekikubo M; Mwesigwa D; Singer J; Biryabarema C; Byamugisha JK; Money DM; Ogilvie GS
Trop Med Int Health; 2015 Oct; 20(10):1355-67. PubMed ID: 26031572
[TBL] [Abstract][Full Text] [Related]
8. A pilot study of community-based self-sampling for HPV testing among non-attenders of cervical cancer screening programs in El Salvador.
Laskow B; Figueroa R; Alfaro KM; Scarinci IC; Conlisk E; Maza M; Chang JC; Cremer M
Int J Gynaecol Obstet; 2017 Aug; 138(2):194-200. PubMed ID: 28589548
[TBL] [Abstract][Full Text] [Related]
9. Operational experiences from the general implementation of HPV self-sampling to Danish screening non-attenders.
Ejegod DM; Pedersen H; Pedersen BT; Serizawa R; Bonde J
Prev Med; 2022 Jul; 160():107096. PubMed ID: 35594924
[TBL] [Abstract][Full Text] [Related]
10. Acceptability of self-collected vaginal samples for human papillomavirus testing for primary cervical cancer screening: comparison of face-to-face and online recruitment modes.
Ngu SF; Lau LS; Chan CY; Ngan HY; Cheung AN; Chan KK
BMC Public Health; 2024 Apr; 24(1):1104. PubMed ID: 38649876
[TBL] [Abstract][Full Text] [Related]
11. [Survey of the acceptance status of HPV self-sampling screening in female population for cervical cancer].
Zhao Y; Liao Q; Mi X; Li MZ; Zhao C; Cui SH; Li JR; Wang Y; Wang JL; Wei LH
Zhonghua Fu Chan Ke Za Zhi; 2019 May; 54(5):312-317. PubMed ID: 31154712
[No Abstract] [Full Text] [Related]
12. HPV self-sampling or the Pap-smear: a randomized study among cervical screening nonattenders from lower socioeconomic groups in France.
Sancho-Garnier H; Tamalet C; Halfon P; Leandri FX; Le Retraite L; Djoufelkit K; Heid P; Davies P; Piana L
Int J Cancer; 2013 Dec; 133(11):2681-7. PubMed ID: 23712523
[TBL] [Abstract][Full Text] [Related]
13. High-risk human papillomavirus detection in self-sampling compared to physician-taken smear in a responder population of the Dutch cervical screening: Results of the VERA study.
Ketelaars PJW; Bosgraaf RP; Siebers AG; Massuger LFAG; van der Linden JC; Wauters CAP; Rahamat-Langendoen JC; van den Brule AJC; IntHout J; Melchers WJG; Bekkers RLM
Prev Med; 2017 Aug; 101():96-101. PubMed ID: 28579497
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of Human Papillomavirus in Self-Taken Samples from Screening Nonattenders.
Lam JUH; Rebolj M; Ejegod DM; Pedersen H; Rygaard C; Lynge E; Harder E; Thomsen LT; Kjaer SK; Bonde J
J Clin Microbiol; 2017 Oct; 55(10):2913-2923. PubMed ID: 28724554
[TBL] [Abstract][Full Text] [Related]
15. Increasing participation in cervical screening by targeting long-term nonattenders: Randomized health services study.
Elfström KM; Sundström K; Andersson S; Bzhalava Z; Carlsten Thor A; Gzoul Z; Öhman D; Lamin H; Eklund C; Dillner J; Törnberg S
Int J Cancer; 2019 Dec; 145(11):3033-3039. PubMed ID: 31032904
[TBL] [Abstract][Full Text] [Related]
16. Acceptability of vaginal self-sampling with high-risk human papillomavirus testing for cervical cancer screening: a French questionnaire-based study.
Bertucci M; Bonnet E; Satger L; Kreiche A; Chappert JL; Loy-Morel S; Segondy M; Daurès JP; Boulle N
Women Health; 2021 Jan; 61(1):83-94. PubMed ID: 33106125
[TBL] [Abstract][Full Text] [Related]
17. Rationale and design of the iPap trial: a randomized controlled trial of home-based HPV self-sampling for improving participation in cervical screening by never- and under-screened women in Australia.
Sultana F; English DR; Simpson JA; Brotherton JM; Drennan K; Mullins R; Heley S; Wrede CD; Saville M; Gertig DM
BMC Cancer; 2014 Mar; 14():207. PubMed ID: 24646201
[TBL] [Abstract][Full Text] [Related]
18. Acceptability of human papillomavirus self-sampling for cervical-cancer screening in under-screened Māori and Pasifika women: a pilot study.
Brewer N; Foliaki S; Bromhead C; Viliamu-Amusia I; Pelefoti-Gibson L; Jones T; Pearce N; Potter JD; Douwes J
N Z Med J; 2019 Jun; 132(1497):21-31. PubMed ID: 31220062
[TBL] [Abstract][Full Text] [Related]
19. Acceptability of self-collected versus provider-collected sampling for HPV DNA testing among women in rural El Salvador.
Rosenbaum AJ; Gage JC; Alfaro KM; Ditzian LR; Maza M; Scarinci IC; Felix JC; Castle PE; Villalta S; Miranda E; Cremer ML
Int J Gynaecol Obstet; 2014 Aug; 126(2):156-60. PubMed ID: 24880188
[TBL] [Abstract][Full Text] [Related]
20. "The best thing is that you are doing it for yourself" - perspectives on acceptability and feasibility of HPV self-sampling among cervical cancer screening clients in Tanzania: a qualitative pilot study.
Bakiewicz A; Rasch V; Mwaiselage J; Linde DS
BMC Womens Health; 2020 Mar; 20(1):65. PubMed ID: 32234028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]